Metabolomics in the Diagnosis and Treatment of Asthma in Children
Recruiting · NCT07280364 · Observational (researchers observe without assigning treatment) · Lead sponsor: I.M. Sechenov First Moscow State Medical University
View the official record on ClinicalTrials.gov →Interventions studied
Standart medical treatment
What this trial is about
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
Who can take part
Age range
12 Years to 17 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age from 12 to 17 years old
- Confirmed diagnosis of asthma
- Informed voluntary consent to participate in the study
Exclusion criteria
- age under 12 years
- no established diagnosis of asthma
- concomitant severe somatic, metabolic, and endocrine diseases
- patient's withdrawal of informed consent
Where it is running
1 location listed.
- I.M. Sechenov First Moscow State Medical University (Sechenov University) - Moscow, Russia